📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Anti-Folate Receptor Alpha-Directed Antibody Therapies Restrict the Growth of Triple-negative Breast Cancer. (2018)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-18-0652

PubMed Identifier: 30068707

Publication URI: http://europepmc.org/abstract/MED/30068707

Type: Journal Article/Review

Volume: 24

Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research

Issue: 20

ISSN: 1078-0432